AKBA ▼ -2.2% - Akebia Therapeutics, Inc. $AKBA - Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026 06-OCT-2026 08:03 AM ET